Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile : a systematic review
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10318 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 27.03.2026. Verfasst von Sumit Raybardhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto Dalla Lana School of Public Health, Canada. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To synthesize evidence on institutional spillover effects of antimicrobial use (AMU) on antimicrobial resistance (AMR) and Clostridioides difficile infections on individuals without direct antimicrobial exposure.
Design
Systematic review.
Methods
Three databases were searched through August 2024 for studies evaluating spillover effects of AMU on unexposed individuals in institutional settings. Study characteristics, AMU, and outcomes were extracted. Study quality was assessed based on underlying methodology to detect spillover effect. A hybrid synthesis, including effect direction and meta-analysis of studies reporting continuous AMU and non-aggregate outcomes was utilized. Reporting followed PRISMA guidelines.
Results
Of 5916 screened studies, five observational studies met inclusion criteria. Three were conducted across 68 hospital wards (ward-level exposure), and two across 693 nursing homes (facility-level exposure). Three studies evaluated all antimicrobial classes; two focused on penicillins, fluoroquinolones, and carbapenems. Two studies examined C. difficile , one MRSA, one carbapenem-resistant Enterobacterales , and one reported combined AMR and C. difficile outcomes. Low to moderate quality evidence indicated a positive spillover effect direction with increasing facility AMU. Meta-analysis of three studies yielded a pooled IRR of 1.54 (95% CI 0.85–2.80) per 100 days of therapy per 1,000 patient-days, with significant heterogeneity ( I 2 = 97.6%).
Conclusions
This review identified five studies suggesting a positive association between institutional AMU and collateral risks of AMR and C. difficile among unexposed individuals. Findings were limited by methodological heterogeneity and potential publication bias. Standardizing terminology, specifying spillover mechanisms, and adopting robust observational designs can enhance future research on spillover effects.
Autor:innen und Institutionen
- University of Toronto Dalla Lana School of Public Health, Canada.
- Public Health Ontario, Canada.
- U of T IHPME: University of Toronto Institute of Health Policy Management and Evaluation, Canada.
- OHRI: Ottawa Hospital Research Institute, Canada.
ORCID-Profile: Sumit Raybardhan, Bradley Langford, Russell Forrest
Zitieren
APA
Raybardhan, S., Langford, B., Forrest, R., Schwartz, K. L., Daneman, N., Macfadden, D. R., & Brown, K. (2026). Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile : a systematic review. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10318
Vancouver
Raybardhan S, Langford B, Forrest R, Schwartz KL, Daneman N, Macfadden DR, et al. Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile : a systematic review. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10318
BibTeX
@article{Raybardhan2026,
author = {Raybardhan, Sumit and Langford, Bradley and Forrest, Russell and Schwartz, Kevin L and Daneman, Nick and Macfadden, Derek R and Brown, Kevin},
title = {Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile : a systematic review},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10318}
}
EUVIMED